The Precision Medicine Molecular Tumor Board (PMMTB) is a service available to oncologists at UW Health and throughout Wisconsin that works in partnership with the UW Collaborative Genomics Core and the UW Carbone Cancer Center (UWCCC).
The PMMTB provides a forum for expert clinicians, pathologists and scientists to discuss and analyze tumor genotypes and molecular abnormalities in order to recommend patient specific targeted therapies. It is intended to supplement oncology tumor boards and includes a broad range of expert panel members.
Case Submissions
Clinicians (UW and non-UW) are welcome to submit a case for review by the PMMTB during their monthly meetings, at no cost to you, the patient or institution. See instructions below.
Cases must be submitted at least 7 days prior to the next meeting.
- Ensure that your patient has had a genomic report ordered and test results obtained. This is required for case submission.
- Complete the online, PHI – compliant case submission form.
- Once the case has been submitted and approved, the submitting clinician will be assigned a date and invited to present at the PMMTB meeting.
Protected Health Information
Because of the online, PHI – compliant nature of our online submission form, patient protected health information (PHI) does not have to be removed.
Treatment Recommendations
Will be discussed at the PMMTB meeting and then faxed and/or emailed to the submitting physician.
Contact Us
Director: Dustin Deming
Manager: Laura Ruelle
Molecular Tumor Board Email: mtb@uwcarbone.wisc.edu
Site Contacts
Gundersen Lutheran: Ben Parsons
ThedaCare Cancer Care: Matthias Weiss
ProHealth: Timothy Wassenaar
Meetings
The PMMTB meets:
- Every first and third Thursday of the month at 4:30pm
- Email MTB@uwcarbone.wisc.edu to be added